FDA Investigator Julian C Hanson

Julian C Hanson has conducted inspections on 283 sites in 14 countries as of 12 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
283
Last Inspection Date:
12 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Hungary, Italy, United Kingdom of Great Britain and Northern Ireland, Netherlands, Spain, France, Austria, Canada, China, India, Israel, Poland, Germany
FDA Investigators that have inspected at least one site in common with Julian C Hanson:
Aaron J Poloni, Abby M Miller, Alan R Condon, Alanna L Mussawwir Bias, Alexander M Kay, Alexandra B Pitkin, Alicia Aborg Borm, Allen F Hall, Amanda E Lewin, PhD, Amber M Howell, Amy M Cramer, Amy R Glynn, Ana Djurdjevic, Andrea A Branche, Andrew K Haack, PhD, Andrew R Wasko, Angela Shepas, Anita Narula, PhD, Annette L Diggs, Arie R Dyk, Armando Chavez, MS, Arsen Karapetyan, Ashleigh P Barkans, Astrida B Mattson, Ava M Bowman, Avery J Dennis, Barbara J Rincon, Barbara Janine Breithaupt, Bradley E Tufto, Brenda K Alford, Brenda L Reihing, Bruce R Burrell, Bryan Baker, Bryce A May, Camille Bennett Hoffman, Carl A Anderson, Carla J Lundi, Carla V Jordan, Catherine J Laufmann, Cathleen A Carr Sharpe, Cathy L Condon, Celena Ngo, Celia L Hutchinstein, Celia L Silverstein, Charles L Larson, Charles R Bonapace, PhD, Cheron M Portee, Cheryl D Mccall, Christina D Mello, Christopher R Czajka, Clint R Van Blaricom, Comyar Shoghi, Connie P Rezendes, Courtney N Long, Crystal A Harlan, Ct Viswanathan, PhD, Dan G Eisenbrey, David J Gomes, David J Hajduk, Dawn E Barkans, Deborah A Greco, Deborah A Nebenzahl, Dennis G Kawabata, Dennis R Hudson, Devon M Shoop, Dewey W Darold, Deyaa Shaheen, Diane Cvan Leeuwen, Diane Hall, Dianna D Wardlow Dotter, Dianne B Latona, Dirk L Lincoln, Doan T Nguyen, PharmD, Dolores E Price, Don A Brunssen, Donald B Mckechnie, Donald W Jehn, Doretha M Tonkins, Doretha M Wilson, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin R Abaonza, Dylan D Yao, MD, PhD, Dylan R Jock, Edward D Harris, Elizabeth S Howell, Emal Wahab, Emily B Camire, Eric C Milstead, Eric S Myskowski, Eric T Huebler, Erica C Gonzalez, Erica R Mahone, Erika V Butler, Erin M Mcdowell, Farhana Khan, Gabriel M Guevarra, Garrad R Poole, Gavin W Pierce, Gene D Arcy, Gerard Pde Leon, Gina C Collins, Gloria A Milster, Gloria J Baca, MS, Gordon T Wales, Grace P Santos, Graham N Giesen, Hanna L Potter, Harmon M Blanch, Heika R Bounds, Heika R Tait, Herminio C Francisco, Hugh A Grimoldby, Hugh M Mcclure, II, Humberto Z Gomez, Ian J Thomson, Jack L Christy, Jacqueline A O'shaughnessy, PhD, James C Henry, James D Hildreth, Jane M Kreis, Janet Pulver, Jasmine Y Wang, Jean Brewer, Jean C Colon Lopez, Jeanne J Thai, Jeanne M Weishaar, Jeannine K Wooten, Jeff A Gard, Jeffrey J Leclair, Jeffrey W Shrifter, DPM, Jennifer C Adams, Jennifer Lalama, Jessica B Clark, Jessica L Walters Moell, Jinkee Mvila Binayug, Jocelyn E Massey, John A Iwen, John E Emmert, John W Banks, Jonathan T Little, Joseph M Hudak, Juanj N Wu, Julia Ventura, Kaarin M Slotte, Kaitlyn T Dang, Karen J Bak, Karen L Bauer, Katherine L Arnold, Kathryn A Krentz, Katlin N Stubbs, Keegan B Mixon, Kelly D Moore, Kelsey A Volkman, Kelsey M Bishop, Kirsten S Tharp, Kirtida Patel, Kristina M Phelps, Kurt M Hafer, Lakecha N Lewis, Lan T Tran, Lance W Bohm, Laura E Hausch, Lauren E Swantko, Laurissa S Flowers, Lawrence Y Lee, PhD, LCDR Ismael Olvera, IV, Leonard H Lavi, Lester O Boian, Leya A Grosch, Linda S Leja, Linda Thai, Lisa A Bowden, Lisa K Capron, Lori J Jennings, Lori J Silverstein, Lorna F Jones, LTJG Bradley E Benasutti, Lucas B Leake, Mai Hang, Marc A Jackson, Jr, Margo C Jones, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Marilyn S Babu, Mark C Saale, Mark E Imsland, Mark E Moen, Mark L Collins, Mark W Babbitt, Marlo Ianm Alintanahin, Marsha L Mccauley, Mary Ewilkerson Brinsko, Mendoza O Wallace, Michael D Garcia, Michael F Schuette, Michael F Skelly, PhD, Michael S Hudson, Michelle A Marsh, Michelle J Hines, Minh D Phan, Mizanne E Lewis, Nancy A Saxenian Emmons, Nancy E Byerly, Nancy E Doyle, Natalie J Ayoub, Neil J Traaen, Nianna C Burns, Nicholas L Hunt, Othello G Capangpangan, Patrick R Brown, Paul F Rader, Paul M Chefor, Paul R Whitby, Paula J Wilkerson, Peter Kessler, PhD, Peter T Regan, Phal K Chhun, Philippe A Cornet, Rachel J Cantrell, Rachelle M Deskins, Rebecca A Sletner, Rebecca T Davis, Richard G Runyon, Richard T Riggie, Rita E Luttrell, Robert A Williams, Robert D Tollefsen, Robert J Vezzetti, Robert S Sweeton, Rocco C Black, Roger J Adams, Ronald E Gill, Ronda Rloyd Jones, S Lori Brown, PhD MPH, Samson O Oluseye, Sandra L Shire, DMD, MPA, Scott A Nabe, Scott B Laufenberg, Selene T Torres, Shannon J Hall, Sharon I Gundersen, Shelagh D Schopen, Sherri J Jackson, Sherri N Rohlf, MD, Sonia R Peterson, Sripal R Mada, PhD, Stephanie A Slater, MS, Stephen R Souza, Stuart W Russell, Sunitha K Rajaram, PhD, Sunny R Muir, Tania Y Hall, Tawny L Colling, Terri L Jones, Thao T Kwan, Thomas C Mclean, CFS, Thomas R Beilke, Timothy D Evans, Timothy P Lafave, Timothy S Williamson, Tonia L Sawyer, Tracy K Li, Trudy R Papson, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Veronica L Bush, Victor A Meo, Victor H Loo, Victoria V Bot, William S Vitale, Willis L Hicks, Xiaojun Yan, Young M Yoon, Yvette Mlacour Davis, Yvonne C Wilkes, Zachary P Wachlarowicz

Julian C Hanson's Documents

Publish Date Document Type Title
June, 2015 FDA 483 Oregon Health & Science University - Form 483, 2015-06-25
March, 2013 FDA 483 Olympia Women's Health - Form 483, 2013-03-01
December, 2011 EIR VisionGift - EIR, 2011-12-02
April, 2017 EIR Eneida R. Nemecek, MD - EIR, 2017-04-14
September, 2019 EIR Altasciences Preclinical Seattle, LLC - EIR, 2019-09-13
May, 2013 EIR George S. Allen, MD - EIR, 2013-05-03
February, 2019 FDA 483 Julio Wainstein - Form 483, 2019-02-13
August, 2021 FDA 483 Chao-Ming C. Lu, MD - Form 483, 2021-08-13
August, 2019 FDA 483 Response Stephen B. Heitner, M.D. - Form 483R, 2019-08-19
April, 2017 FDA 483 Eneida R. Nemecek, MD - Form 483, 2017-04-14
May, 2017 FDA 483 Alan F. Barker, MD - Form 483, 2017-05-31
April, 2019 FDA 483 Balamurali K. Ambati , M.D., Ph.D. - Form 483, 2019-04-04
February, 2012 FDA 483 Jau-Shin Lou, MD, Ph.D. - Form 483, 2012-02-29
May, 2022 FDA 483 Maynard R. Rasmussen, M.D - Form 483, 2022-05-06
May, 2016 FDA 483 Response James W. Baker, MD - Form 483R, 2016-06-16
November, 2012 EIR Lynn K. Boshkov, M.D. - EIR, 2012-11-14
June, 2018 FDA 483 Kevin L. Winthrop, M.D., M.P.H. - Form 483, 2018-06-14
November, 2020 FDA 483 Neil Sheth, MD - Form 483, 2020-11-24
February, 2012 EIR Jau-Shin Lou, MD, Ph.D. - EIR, 2012-02-29
August, 2016 EIR Matthew Taylor, M.D. - EIR, 2016-08-26
November, 2012 FDA 483 Lynn K. Boshkov, M.D. - Form 483, 2012-11-14
December, 2019 FDA 483 Ines Guttmann-Bauman MD - Form 483, 2019-12-12
July, 2017 FDA 483 Stacy R. Smith, M.D. - Form 483, 2017-07-26
December, 2021 EIR Legacy Health IRB - EIR, 2021-12-17
May, 2021 FDA 483 Jeremy Cetnar, MD - Form 483, 2021-05-06
May, 2016 EIR James W. Baker, MD - EIR, 2016-05-26
September, 2019 FDA 483 Altasciences Preclinical Seattle, LLC - Form 483, 2019-09-13
July, 2023 FDA 483 Altasciences Preclinical Seattle, LLC - Form 483, 2023-07-14
November, 2017 FDA 483 Julie N. Graff, MD - Form 483, 2017-11-14
May, 2021 FDA 483 Anjay Rastogi, MD, PhD - Form 483, 2021-05-21
May, 2013 FDA 483 George S. Allen, MD - Form 483, 2013-05-03
February, 2012 FDA 483 Response Jau-Shin Lou, MD, Ph.D. - Form 483R, 2012-03-14
April, 2019 FDA 483 Response Balamurali K. Ambati , M.D., Ph.D. - Form 483R, 2019-04-07
September, 2021 FDA 483 Salil U. Nadkarni, DO - Form 483, 2021-09-24
February, 2023 FDA 483 Cameron G. Javid, M.D. - Form 483, 2023-02-16
February, 2018 FDA 483 Hormozd Bozorgchami, MD - Form 483, 2018-02-07
May, 2022 FDA 483 Richard H. Hass, M.D. - Form 483, 2022-05-13
October, 2017 EIR Aude G. Chapuis, M.D. - EIR, 2017-10-13
August, 2016 FDA 483 Response Matthew Taylor, M.D. - Form 483R, 2016-09-09
August, 2019 FDA 483 Stephen B. Heitner, M.D. - Form 483, 2019-08-19
October, 2017 FDA 483 Aude G. Chapuis, M.D. - Form 483, 2017-10-13
March, 2017 FDA 483 Saad F Jazrawi MD - Form 483, 2017-03-23
May, 2016 FDA 483 James W. Baker, MD - Form 483, 2016-05-26
May, 2017 EIR Alan F. Barker, MD - EIR, 2017-05-31
June, 2015 FDA 483 Response Oregon Health & Science University - Form 483R, 2015-06-29
April, 2017 FDA 483 Response Eneida R. Nemecek, MD - Form 483R, 2017-05-02
November, 2014 FDA 483 Beal G. Essink, MD - Form 483, 2014-11-06
August, 2016 FDA 483 Matthew Taylor, M.D. - Form 483, 2016-08-26
December, 2021 FDA 483 Legacy Health IRB - Form 483, 2021-12-17

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more